Tilray Brands Future Growth
Future criteria checks 1/6
Tilray Brands is forecast to grow earnings and revenue by 72% and 7.9% per annum respectively. EPS is expected to grow by 69.9% per annum. Return on equity is forecast to be -1% in 3 years.
Key information
72.0%
Earnings growth rate
69.9%
EPS growth rate
| Pharmaceuticals earnings growth | 21.5% |
| Revenue growth rate | 7.9% |
| Future return on equity | -1.0% |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 5/31/2027 | 1,041 | -9 | N/A | 113 | 4 |
| 5/31/2026 | 958 | -75 | 15 | 51 | 10 |
| 5/31/2025 | 904 | -89 | 10 | -27 | 12 |
| 8/31/2024 | 812 | -213 | -82 | -50 | N/A |
| 5/31/2024 | 789 | -245 | -60 | -31 | N/A |
| 2/29/2024 | 743 | -368 | -50 | -18 | N/A |
| 11/30/2023 | 700 | -1,446 | -45 | -21 | N/A |
| 8/31/2023 | 651 | -1,458 | 16 | 38 | N/A |
| 5/31/2023 | 627 | -1,453 | -13 | 8 | N/A |
| 2/28/2023 | 596 | -1,792 | -70 | -56 | N/A |
| 11/30/2022 | 603 | -578 | -102 | -84 | N/A |
| 8/31/2022 | 614 | -501 | -151 | -130 | N/A |
| 5/31/2022 | 628 | -477 | -211 | -177 | N/A |
| 2/28/2022 | 617 | 42 | -182 | -148 | N/A |
| 11/30/2021 | 589 | -275 | -134 | -101 | N/A |
| 8/31/2021 | 564 | -375 | -123 | -82 | N/A |
| 5/31/2021 | 513 | -367 | -84 | -45 | N/A |
| 2/28/2021 | 468 | -521 | -109 | -58 | N/A |
| 11/30/2020 | 462 | -243 | -182 | -105 | N/A |
| 8/31/2020 | 426 | -149 | -221 | -138 | N/A |
| 5/31/2020 | 405 | -103 | -199 | -101 | N/A |
| 2/29/2020 | 387 | 22 | -215 | -104 | N/A |
| 11/30/2019 | 338 | -63 | -198 | -78 | N/A |
| 8/31/2019 | 263 | -16 | -190 | -49 | N/A |
| 5/31/2019 | 179 | -25 | -198 | -42 | N/A |
| 2/28/2019 | 92 | -28 | -194 | -33 | N/A |
| 11/30/2018 | 43 | 63 | -211 | -17 | N/A |
| 8/31/2018 | 34 | 27 | -195 | -12 | N/A |
| 5/31/2018 | 28 | 23 | N/A | -4 | N/A |
| 2/28/2018 | 24 | 25 | N/A | 1 | N/A |
| 11/30/2017 | 20 | 18 | N/A | 3 | N/A |
| 8/31/2017 | 18 | 15 | N/A | 0 | N/A |
| 5/31/2017 | 15 | 3 | N/A | 4 | N/A |
| 2/28/2017 | 13 | 6 | N/A | 4 | N/A |
| 11/30/2016 | 11 | 2 | N/A | 2 | N/A |
| 8/31/2016 | 9 | 1 | N/A | 1 | N/A |
| 5/31/2016 | 6 | 0 | N/A | -1 | N/A |
| 2/29/2016 | 5 | -1 | N/A | -2 | N/A |
| 11/30/2015 | 3 | -3 | N/A | -3 | N/A |
| 8/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 5/31/2015 | 0 | -5 | N/A | -4 | N/A |
| 2/28/2015 | 0 | -5 | N/A | -4 | N/A |
| 11/30/2014 | N/A | -3 | N/A | -2 | N/A |
| 8/31/2014 | N/A | -3 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2HQ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2HQ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2HQ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2HQ's revenue (7.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2HQ's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2HQ is forecast to be unprofitable in 3 years.